Page last updated: 2024-11-05
ticlopidine and Depression
ticlopidine has been researched along with Depression in 2 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
Fihn, SD | 1 |
Gardin, JM | 1 |
Abrams, J | 1 |
Berra, K | 1 |
Blankenship, JC | 1 |
Dallas, AP | 1 |
Douglas, PS | 1 |
Foody, JM | 1 |
Gerber, TC | 1 |
Hinderliter, AL | 1 |
King, SB | 1 |
Kligfield, PD | 1 |
Krumholz, HM | 1 |
Kwong, RY | 1 |
Lim, MJ | 1 |
Linderbaum, JA | 1 |
Mack, MJ | 1 |
Munger, MA | 1 |
Prager, RL | 1 |
Sabik, JF | 1 |
Shaw, LJ | 1 |
Sikkema, JD | 1 |
Smith, CR | 1 |
Smith, SC | 1 |
Spertus, JA | 1 |
Williams, SV | 1 |
Tibold, A | 1 |
Feher, G | 1 |
Csejtei, A | 1 |
Tettinger, A | 1 |
Kiss, I | 1 |
Clinical Trials (2)
Trial Overview
Trial | Phase | Enrollment | Study Type | Start Date | Status |
Routine Or Selective Stress Testing After Revascularization: ROSSTAR Trial RCT Outline[NCT03067402] | | 1,100 participants (Anticipated) | Interventional | 2017-03-20 | Not yet recruiting |
Register of Cardiovascular Complications Among People Living With HIV[NCT02453919] | | 800 participants (Anticipated) | Observational [Patient Registry] | 2010-02-28 | Recruiting |
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Other Studies
2 other studies available for ticlopidine and Depression
Article | Year |
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and theJournal of the American College of Cardiology, 2012, Dec-18, Volume: 60, Issue:24
Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Alcohol Drinking; Angina Pectoris; Body Weight | 2012 |
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and theJournal of the American College of Cardiology, 2012, Dec-18, Volume: 60, Issue:24
Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Alcohol Drinking; Angina Pectoris; Body Weight | 2012 |
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and theJournal of the American College of Cardiology, 2012, Dec-18, Volume: 60, Issue:24
Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Alcohol Drinking; Angina Pectoris; Body Weight | 2012 |
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and theJournal of the American College of Cardiology, 2012, Dec-18, Volume: 60, Issue:24
Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Alcohol Drinking; Angina Pectoris; Body Weight | 2012 |
Selective serotonin reuptake inhibitors may interfere with the antiplatelet effect of clopidogrel.The American journal of cardiology, 2007, Apr-01, Volume: 99, Issue:7
Topics: Antidepressive Agents, Second-Generation; Clopidogrel; Coronary Artery Bypass; Coronary Artery Disea | 2007 |